Mohamad E Allaf

Professor

19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mohamad E Allaf is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Nephrectomy Medicine & Life Sciences
Kidney Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Robotics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Kidney Neoplasms Medicine & Life Sciences
Lymph Node Excision Medicine & Life Sciences
Prostatectomy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

Interleukin-2
T-Lymphocytes
Kidney
Proteins
2,6-dinitrotoluene

Adjuvant Therapy for Urothelial and Renal Cell Carcinoma

Patel, H. D., Kates, M. & Allaf, M. E., Jan 1 2019, In : European Urology Focus.

Research output: Contribution to journalComment/debate

Renal Cell Carcinoma
Therapeutics

Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States

Patel, H. D., Gupta, M., Joice, G. A., Srivastava, A., Alam, R., Allaf, M. E. & Pierorazio, P. M., Jul 1 2019, In : European Urology Oncology. 2, 4, p. 343-348 6 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Survival
Neoplasms
Therapeutics
Databases

Consumers' association of hospital reputation with healthcare quality

Ziemba, J. B., Arenberg, S., Reustle, H., Allaf, M. E. & Haldeman, D., Jul 1 2019, In : Journal for Healthcare Quality. 41, 4, p. 251-258 8 p.

Research output: Contribution to journalArticle

Quality of Health Care
Hispanic Americans
African Americans
Health Services
Hospitalization
Renal Cell Carcinoma
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
Neoplasms
Prospective Studies
Neoplasm Metastasis